磺脲类药物无法抑制人体血浆胰高血糖素。 - Suppr

Suppr

超能文献

Failure of sulfonylureas to suppress plasma glucagon in man.

作者信息

Pek S, Fajans S S, Floyd J C, Knopf R F, Conn J W

出版信息

Diabetes. 1972 Apr;21(4):216-23. doi: 10.2337/diab.21.4.216.

DOI:10.2337/diab.21.4.216

PMID:5017378

Abstract

摘要

相似文献

Failure of sulfonylureas to suppress plasma glucagon in man.磺脲类药物无法抑制人体血浆胰高血糖素。

Diabetes. 1972 Apr;21(4):216-23. doi: 10.2337/diab.21.4.216.

Effect of short and long term chlorpropamide treatment of insulin release and blood-glucose.短期和长期氯磺丙脲治疗对胰岛素释放及血糖的影响。

Lancet. 1974 Jul 13;2(7872):69-72. doi: 10.1016/s0140-6736(74)91634-1.

Unaltered glucagon secretion after seven days of sulphonylurea administration in normal subjects.正常受试者服用磺脲类药物七天后胰高血糖素分泌未受影响。

Diabetologia. 1973 Sep:317-9. doi: 10.1007/BF01218441.

Exaggerated intestinal glucagon and insulin responses in human subjects.人类受试者中肠道胰高血糖素和胰岛素反应过度。

Metabolism. 1972 May;21(5):405-12. doi: 10.1016/0026-0495(72)90053-4.

[Current views on the mode of action of hypoglycemic sulfonamides].

Acta Diabetol Lat. 1969 Sep;6 Suppl 1:201-15.

Correlation among glucose, insulin, and orally administered SPC-703 blood-levels in rats and rabbits.大鼠和兔子体内葡萄糖、胰岛素及口服SPC - 703血药浓度之间的相关性。

Pol J Pharmacol Pharm. 1975 Jan-Feb;27(1):45-52.

[Pharmacological aspects of comparative studies on different blood sugar-lowering sulfonylureas].[不同降血糖磺脲类药物比较研究的药理学方面]

Arzneimittelforschung. 1973 Nov;23(11):Suppl:1668-75.

Effect of sulfonylureas on the secretion of pancreatic immunoreactive glucagon and enteric glucagon-like immunoreactivity.磺酰脲类药物对胰腺免疫反应性胰高血糖素分泌及肠胰高血糖素样免疫反应性的影响。

Can J Physiol Pharmacol. 1973 Dec;51(12):990-2. doi: 10.1139/y73-149.

[Action of the sulfonylureas tolbutamide and glypentide on the lacticdehydrogenase plasma levels (author's transl)].磺脲类药物甲苯磺丁脲和格列戊脲对血浆乳酸脱氢酶水平的作用（作者译）

Rev Esp Fisiol. 1974 Jun;30(2):91-6.

[Comparative use of gliquidone and tolbutamide administered intravenously].静脉注射格列喹酮与甲苯磺丁脲的比较应用

MMW Munch Med Wochenschr. 1975 Sep 5;117(36):1421-2.

引用本文的文献

Modelling the electrical activity of pancreatic alpha-cells based on experimental data from intact mouse islets.基于完整小鼠胰岛的实验数据对胰腺α细胞的电活动进行建模。

J Biol Phys. 2006 Oct;32(3-4):209-29. doi: 10.1007/s10867-006-9013-0. Epub 2006 Nov 9.

Effects of glimepiride on insulin and glucagon release from isolated rat pancreas at different glucose concentrations.不同葡萄糖浓度下格列美脲对离体大鼠胰腺胰岛素和胰高血糖素释放的影响。

Acta Diabetol. 1996 Mar;33(1):25-9. doi: 10.1007/BF00571936.

Clinical pharmacology of sulphonylurea hypoglycaemic agents: part 2.磺酰脲类降糖药的临床药理学：第2部分。

Drugs. 1981 Oct;22(4):295-320. doi: 10.2165/00003495-198122040-00003.

Unaltered glucagon secretion after seven days of sulphonylurea administration in normal subjects.正常受试者服用磺脲类药物七天后胰高血糖素分泌未受影响。

Diabetologia. 1973 Sep:317-9. doi: 10.1007/BF01218441.

Sulfonylurea-induced inhibition of glucagon secretion from the perfused rat pancreas: evidence for a direct, non-paracrine effect.磺脲类药物对灌注大鼠胰腺胰高血糖素分泌的抑制作用：直接非旁分泌效应的证据

Diabetologia. 1986 Dec;29(12):861-7. doi: 10.1007/BF00870141.

Hyperuricemia in glycogen storage disease type I. Contributions by hypoglycemia and hyperglucagonemia to increased urate production.I型糖原贮积病中的高尿酸血症。低血糖和高胰高血糖素血症对尿酸生成增加的作用。

J Clin Invest. 1985 Jan;75(1):251-7. doi: 10.1172/JCI111681.

[Clinical investigations of the effect of tolbutamide and glibenclamide on pancreatic glucagon secretion (author's transl)].

Klin Wochenschr. 1975 Jun 15;53(12):571-4. doi: 10.1007/BF01468901.

Plasma glucagon in insulinoma.胰岛素瘤患者的血浆胰高血糖素

Acta Diabetol Lat. 1977 Sep-Dec;14(5-6):219-28. doi: 10.1007/BF02580970.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验